Home/Filings/4/0001415889-25-017620
4//SEC Filing

Zhao Baiteng 4

Accession 0001415889-25-017620

CIK 0001422142other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 8:10 PM ET

Size

6.1 KB

Accession

0001415889-25-017620

Insider Transaction Report

Form 4
Period: 2025-06-17
Zhao Baiteng
Director
Transactions
  • Award

    Stock Option (right to buy)

    2025-06-17+40,00640,006 total
    Exercise: $2.04Exp: 2035-06-17Common Stock (40,006 underlying)
Footnotes (1)
  • [F1]Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) June 12, 2026 or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2025.

Issuer

Whitehawk Therapeutics, Inc.

CIK 0001422142

Entity typeother

Related Parties

1
  • filerCIK 0002049287

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 8:10 PM ET
Size
6.1 KB